Smith & Nephew Plc
(NYSE : SNN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 0.47%23.386.3%$1311.41m
TMOThermo Fisher Scientific, Inc. -1.32%382.561.0%$555.58m
DXCMDexCom, Inc. -0.20%439.648.2%$525.71m
MDTMedtronic Plc 0.77%90.820.6%$523.27m
BDXBecton, Dickinson & Co. -0.50%257.331.0%$495.38m
ABTAbbott Laboratories -0.67%93.040.8%$494.90m
DHRDanaher Corp. -0.95%183.700.7%$446.67m
BSXBoston Scientific Corp. 0.52%34.681.0%$429.44m
QDELQuidel Corp. 0.69%246.647.7%$412.12m
ISRGIntuitive Surgical, Inc. 0.24%575.872.4%$333.95m
SYKStryker Corp. 0.07%177.891.3%$308.55m
BAXBaxter International, Inc. -0.53%85.241.8%$275.66m
ALGNAlign Technology, Inc. -0.29%273.296.4%$224.28m
ZBHZimmer Biomet Holdings, Inc. 1.52%119.431.7%$205.29m
BIOBio-Rad Laboratories, Inc. -0.03%477.902.9%$199.18m

Company Profile

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.